Accordingly, our primary objectives were to assess in the diaphragms of patients with COPD, the expression of a wide number of epigenetic mechanisms including muscle-enriched miRNAs, as well as the expression of SUMO-2/3. The gene discussed is SUMO2; the disease is chronic obstructive pulmonary disease.